Green Cross Health Limited (NZE:GXH)

Market Cap	127.91M
Revenue (ttm)	523.76M
Net Income (ttm)	15.98M
Shares Out	143.72M
EPS (ttm)	0.11
PE Ratio	8.02
Forward PE	n/a
Dividend	0.05 (6.10%)
Ex-Dividend Date	Jun 5, 2025

Volume	2,346
Average Volume	20,723
Open	0.8900
Previous Close	0.8900
Day's Range	0.8700 - 0.8900
52-Week Range	0.7100 - 0.9000
Beta	0.05
RSI	62.79
Earnings Date	Aug 26, 2025

About Intra-Cellular Therapies

Green Cross Health Limited provides health care and advice services to communities in New Zealand. It operates through Pharmacy Services and Medical Services segments. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores. It operates approximately 345 community pharmacies under the Unichem and Life Pharmacy brands. The Medical Services segment operates owned and equity accounted medical centres; and offers support services provided to its medical centres, as well as medical ce...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1999
• Employees: 5,700
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: GXH

Financial Performance

In 2024, Green Cross Health's revenue was 523.76 million, an increase of 3.94% compared to the previous year's 503.92 million. Earnings were 15.98 million, an increase of 35.88%.